Financial Results Summary

Hexagon Nutrition Limited announced its financial results for the quarter and half year ended September 30, 2026 (Q2 & H1 FY27).

Consolidated Financial Performance (₹ Crore)

| Particulars | Q2 FY27 | Q2 FY26 | YoY Change | H1 FY27 | H1 FY26 | YoY Change |

| Revenue from Operations | 109.7 | 95.2 | 15.2% | 214.0 | 168.0 | 27.3% |

| Gross Profit | 51.6 | 50.5 | 2.1% | 97.4 | 84.7 | 15.0% |

| EBITDA | 10.9 | 12.2 | (11.3%) | 22.7 | 22.3 | 1.6% |

| EBITDA Margin | 9.9% | 12.9% | (300 bps) | 10.6% | 13.3% | (270 bps) |

| Profit Before Tax | 10.1 | - | - | 20.8 | - | - |

| Profit After Tax | 8.2 | 10.1 | (19.6%) | 16.2 | 16.6 | (2.3%) |

| PAT Margin | 7.4% | 10.6% | (320 bps) | 7.6% | 9.9% | (231 bps) |

| Basic EPS (₹) | 0.74 | 0.92 | - | 1.41 | 1.50 | - |

| Diluted EPS (₹) | 0.66 | 0.82 | - | 1.32 | 1.35 | - |

Note: EBITDA computed as Profit before Tax + Finance Cost + Depreciation & Amortization less Other Income

Performance Analysis

Revenue Growth:

  • H1 FY27 revenue reached ₹214.0 crore, showing strong 27.3% YoY growth from ₹168.0 crore in H1 FY26
  • Q2 FY27 revenue stood at ₹109.7 crore, up 15.2% YoY from ₹95.2 crore in Q2 FY26

Profitability Metrics:

  • Gross profit increased 15.0% YoY to ₹97.4 crore in H1 FY27 from ₹84.7 crore
  • EBITDA showed modest growth of 1.6% YoY to ₹22.7 crore in H1 FY27
  • EBITDA margins contracted significantly: 270 bps decline in H1 FY27 (10.6% vs 13.3%) and 300 bps decline in Q2 FY27 (9.9% vs 12.9%)
  • PAT declined 2.3% YoY to ₹16.2 crore in H1 FY27 from ₹16.6 crore
  • PAT margins declined 231 bps in H1 FY27 (7.6% vs 9.9%) and 320 bps in Q2 FY27 (7.4% vs 10.6%)

Management Commentary

Mr. Arun Kelkar, Chairman & Executive Director, commented:

  • Company maintained healthy revenue momentum with 15.2% YoY growth in Q2 FY27 and 27.3% in H1 FY27
  • Margins moderated compared to previous year
  • Focus areas include improving operational efficiencies and strengthening profitability
  • Future strategy includes expanding international presence, strengthening domestic distribution network, and developing innovative nutrition solutions
  • Key business segments: Micronutrient Premixes, Clinical Nutrition, and Therapeutic Nutrition
  • Operational priorities: strengthening operational capabilities, improving capacity utilization, driving efficiencies
  • Commitment to enhancing product portfolio and expanding market reach
  • Leveraging integrated manufacturing and R&D capabilities to capture emerging opportunities

Business Overview

Hexagon Nutrition Limited is described as a leading global nutrition company engaged in:

  • Manufacturing and marketing of micronutrient premixes
  • Therapeutic nutrition products
  • Clinical nutrition
  • Food fortification solutions
  • Consumer nutrition products

Operational Footprint:

  • Four manufacturing facilities: Nashik (Maharashtra), Chennai (Tamil Nadu), Thoothukudi (Tamil Nadu), Tashkent (Uzbekistan)
  • Global presence through subsidiaries and offices in India, South Africa, Uzbekistan, and Hong Kong
  • Serves customers across India and international markets
  • Customer segments: food manufacturers, pharmaceutical companies, healthcare institutions, consumers
  • Supported by strong research and development capabilities